MUSCLE-INVASIVE BLADDER CARCINOMA
Clinical trials for MUSCLE-INVASIVE BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE-INVASIVE BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE-INVASIVE BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Bladder-Saving cancer treatment shows promise
Disease control OngoingThis study is testing a treatment plan for muscle-invasive bladder cancer that aims to avoid major surgery. It combines chemotherapy, an immunotherapy drug (toripalimab), and radiation therapy to try to eliminate the cancer while preserving the patient's bladder. The main goals a…
Matched conditions: MUSCLE-INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Targeted drug combo tested to fight tough bladder cancer
Disease control TerminatedThis study aimed to see if a targeted pill (erdafitinib) alone or combined with an immunotherapy drug (atezolizumab) could shrink aggressive bladder tumors before surgery. It was for patients whose cancer had grown into the muscle wall of the bladder and who could not receive the…
Matched conditions: MUSCLE-INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Major trial aims to boost bladder cancer survival with new drug combo
Disease control OngoingThis large, late-stage trial is testing whether adding an immunotherapy drug (atezolizumab) to standard chemotherapy and radiation treatment works better for patients with muscle-invasive bladder cancer. The main goal is to see if the combination helps patients live longer while …
Matched conditions: MUSCLE-INVASIVE BLADDER CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
New radiation tech aims to spare cancer patients from severe diarrhea
Symptom relief OngoingThis trial is testing a more precise, daily-adapted form of radiation therapy for muscle-invasive bladder cancer. The main goal is to see if this method causes fewer severe intestinal side effects, like diarrhea, compared to standard radiation. It involves 110 participants and fo…
Matched conditions: MUSCLE-INVASIVE BLADDER CARCINOMA
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC